Viatris (VTRS) Announces Positive Top-line Results from VEGA-3
Viatris Inc. (NASDAQ:VTRS) is one of the Most Undervalued Stocks Under $10 to Buy Now.
Viatris Inc (VTRS)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Deerfield Management James E. Flynn | 23,991,594 | $208,966,784 | -1% | 4.13% |
| 2. | Glenview Capital Larry Robbins | 8,492,943 | $73,973,534 | -9% | 1.82% |
| 3. | Camber Capital Management Stephen Dubois | 7,500,000 | $65,325,000 | -50% | 2.32% |
| 4. | Invenomic Capital Management Ali Motamed | 6,436,632 | $56,063,065 | +98% | 2.83% |
| 5. | Citadel Investment Group Ken Griffin | 6,152,041 | $53,584,277 | -39% | 0.01% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $8.94 | 60,000 | $536,262.00 | 292,807 | 2025-05-12 | Filing | |
| $9.01 | 19 | $171.13 | 94,960 | 2023-10-26 | Filing | |
| $10.42 | 239 | $2,488.12 | 94,190 | 2022-03-16 | Filing | |
| $10.08 | 1,150 | $11,590.85 | 93,951 | 2022-03-04 | Filing | |
| $12.84 | 176 | $2,261.32 | 92,801 | 2021-12-16 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $12.88 | 26,925 | $346,686.30 | 126,901 | 2024-11-11 | Filing | |
| $11.66 | 139,681 | $1,628,163.64 | 505,838 | 2024-09-12 | Filing | |
| $11.71 | 60,319 | $706,552.64 | 0 | 2024-09-12 | Filing | |
| $12.00 | 50,000 | $600,000.00 | 60,319 | 2024-08-30 | Filing | |
| $11.90 | 50,000 | $595,075.00 | 110,319 | 2024-08-28 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 3,972,451 | $35,473,987 | 0.05% | |
| 2. | 3,369,610 | $30,090,617 | 0.54% | |
| 3. | 1,177,250 | $10,542,274 | 9.71% | |
| 4. | 590,228 | $5,270,736 | 0.25% | |
| 5. | 411,588 | $3,675,482 | 0.21% |
News See All
11 Most Undervalued Stocks Under $10 to Buy Now
According to David Kostin (Chief US equity strategist in Goldman Sachs Research), apart from the improved outlook for interest rates, the strength of Q1 2025 earnings results strengthened the confidence...
Viatris Gains China Approval for COPD Drug Yupelri, Triggers $7.5M Payment to Theravance BioPharma
Viatris Inc. (NASDAQ:VTRS) is one of the best low priced pharma stocks to buy now.
13 Best Low Priced Pharma Stocks to Buy Now
On July 9, Afsaneh Beschloss, RockCreek Group founder & CEO, joined 'Closing Bell Overtime' on CNBC to talk about the latest round of tariff threats.
13 Best Healthcare Stocks to Buy Under $10
On June 27, Tiffany McGhee, CEO of Pivotal Advisors, appeared on CNBC to talk about the best course of action for investors amid current market dynamics.
Viatris (VTRS) Faces Securities Fraud Class Action Over FDA Inspection Fallout
On May 31, 2025, Viatris Inc. (NASDAQ:VTRS) became the subject of a securities fraud class action lawsuit filed in the U.S. District Court for the Western District of Pennsylvania.
Viatris Inc. (NASDAQ:VTRS) Q1 2025 Earnings Call Transcript
Operator: Good morning, everyone, and welcome to the Viatris Q1 2025 Earnings Call. All participants will be in a listen-only mode.
11 Worst Performing Stocks in S&P 500 So Far in 2025
After a two-year surge of 53%, marking the best performance for the broad market index since the 1997-98 rally, stocks have been taken for a wild ride in 2025 due to uncertainties around recent tariffs...
10 Cheap Quarterly Dividend Stocks to Buy Now
In the current market environment, investors are looking to seek stable income as a way to protect themselves against a possible recession.
Billionaire Ken Fisher's 10 Healthcare Stock Picks with Massive Upside Potential
The healthcare industry, an essential component of global well-being and economic resilience, is undergoing significant changes.
Billionaire Hedge Funds
